Toggle navigation
Peak Browser
Enrichment Analysis
Diff Analysis
Target Genes
Colocalization
Publications
Docs
Search
Go
Find By ID
Visualize
Install and launch IGV before selecting data to visualize
For mm10
BigWig
Peak-call (q < 1E-05)
Peak-call (q < 1E-10)
Peak-call (q < 1E-20)
For mm9
BigWig
Peak-call (q < 1E-05)
Peak-call (q < 1E-10)
Peak-call (q < 1E-20)
Error connecting to IGV?
Analyze
For mm10
Colocalization
Target Genes (TSS ± 1kb)
Target Genes (TSS ± 5kb)
Target Genes (TSS ± 10kb)
For mm9
Colocalization
Target Genes (TSS ± 1kb)
Target Genes (TSS ± 5kb)
Target Genes (TSS ± 10kb)
Download
For mm10
BigWig
Peak-call (q < 1E-05)
Peak-call (q < 1E-10)
Peak-call (q < 1E-20)
For mm9
BigWig
Peak-call (q < 1E-05)
Peak-call (q < 1E-10)
Peak-call (q < 1E-20)
Link Out
Sequence Read Archive
DBCLS SRA
NCBI SRA
ENA
Antigen: Cebpa
wikigenes
PDBj
CellType: Myeloid leukemia
ATCC
MeSH
RIKEN BRC
SRX2980167
GSM2692616: ChIP mouseMA9 Cebpa control; Mus musculus; ChIP-Seq
Sample information curated by ChIP-Atlas
Antigen
Antigen Class
TFs and others
Antigen
Cebpa
Cell type
Cell type Class
Blood
Cell type
Myeloid leukemia
NA
NA
Attributes by original data submitter
Sample
source_name
MA9-transformed mouse leukemia
tissue
bone marrow
cell markers
Lin-Sca-1+c-Kit+
genotype
MLL-AF9 fusion
chip antibody
anti-Cebpa (Santa Cruz, sc-61)
treatment
none
Sequenced DNA Library
library_strategy
ChIP-Seq
library_source
GENOMIC
library_selection
ChIP
library_construction_protocol
ChIP-seq libraries were constructed with the NEBNext ChIP-seq library prep kit following the manufacturer’s recommended protocol (New England Biolabs, Ipswich, MA, USA).
Sequencing Platform
instrument_model
Illumina HiSeq 2000
Where can I get the processing logs?
Read processing pipeline
log
mm10
Number of total reads
14099116
Reads aligned (%)
92.9
Duplicates removed (%)
23.0
Number of peaks
16078 (qval < 1E-05)
mm9
Number of total reads
14099116
Reads aligned (%)
92.5
Duplicates removed (%)
23.1
Number of peaks
16115 (qval < 1E-05)
Base call quality data from
DBCLS SRA